Infectious complications in systemic lupus erythematosus: A series of 146 patients;Complications infectieuses au cours du lupus érythémateux systémique : étude de 146 patients

Revue de Medecine Interne

Volumn 29, Issue 8, 2008, Pages 626-631

  Jallouli, M ^a   Frigui, M ^a   Marzouk, S ^a   Maaloul I ^a   Kaddour, N ^a   Bahloul, Z ^a  

^a HEDI CHAKER HOSPITAL   (Tunisia)

Author keywords

Infections; Systemic lupus erythematosus

Indexed keywords

CYCLOPHOSPHAMIDE; STEROID;

ARTICLE; BACTERIAL INFECTION; COMPLEMENT SYSTEM; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG USE; HUMAN; INCIDENCE; LEUKOPENIA; LUNG INFECTION; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; NEPHRITIS; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INFECTION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TUNISIA;

EID: 48149095854     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2008.02.023     Document Type: Article

References (28)

1. Barri J., and Fessler M.D. Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis. Best Pract Res Clin Rheumatol 16 (2002) 281-291
2. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., Mac Shane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25 (1982) 1271-1277
3. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40 (1997) 1725
4. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., Chang C.H., and The Committee on Prognosis Studies in SLE. The developement and validation of the SLE disease Activity Index (SLEDAI). Arthritis Rheum 35 (1992) 630-640
5. Bach J.-F. Infections and autoimmune diseases. J Autoimmun 25 (2005) 74-80
6. Zonana-Nacach A., Camargo-Coronel A., Yanez P., Sanchez L., Jimenez-Balderas F.J., and Fraga A. Infections in outpatients with systemic lupus erythematosus: a prospective study. Lupus 10 (2001) 505-510
7. Noël V., Lortholary O., Casassus P., Cohen P., Généreau T., André M.-H., et al. Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann Rheum Dis 60 (2001) 1141-1144
8. Gladman D.D., Hussain F., Ibanez D., and Urowitz M.B. The nature and outcome of infection in systemic lupus erythematosus. Lupus 11 (2002) 234-239
9. Shyam C., and Malaviya A.N. Infection-related morbidity in systemic lupus erythematosus: a clinico-epidemiological study from northern India. Rheumatol Int 16 (1996) 1-3
10. Bosch X., Guilabert A., Pallarés L., Cervera R., Ramos-Casals M., Bové A., et al. Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients. Lupus 15 (2006) 584-589
11. Kang I., and Park S.H. Infectious complications in SLE after immunosuppressive therapies. Curr Opin Rheumatol 15 (2003) 528-534
12. Lecocq P., Guerbeau G., Mikolajcz E., and Wyderkiewicz. Septicémie à salmonelle révélatrice d'un lupus érythémateux disséminé. Rev Med Interne 18 (1997) 992-993
13. Mitchell S.R., Nguyen P.Q., and Katz P. Increased risk of neisserial infections in systemic lupus erythematosus. Semin Arthritis Rheum 20 (1990) 174-184
14. Le Moing V., and Leport C. Infections et lupus. Rev Prat (Paris) 48 (1998) 637-642
15. Chen H.S., Tsai W.P., Leu1 H.S., Ho H.H., and Liou L.B. Invasive fungal infection in systemic lupus erythematosus: an analysis of 15 cases and a literature review. Rheumatology 46 (2007) 539-544
16. Hellmann D.B., Petri M., and Whiting-O'Keefe Q. Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms. Medecine (Baltimore) 66 (1987) 341-348
17. Pryor B.D., Bologna S.G., and Kahl L.E. Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. Arthritis Rheum 39 (1996) 1475-1482
18. Liam C.K., and Wang F. Pneumocystis carinii pneumonia in a patients with systemic lupus erythematosus. Lupus 1 (1992) 379-385
19. Hausfater P. Le dosage de la procalcitonine en pratique clinique chez l'adulte. Rev Med Interne 28 (2007) 296-305
20. Shin K.C., Lee Y.J., Kang S.W., Baek H.J., Lee E.B., Kim H.A., et al. Serum procalcitonin measurement for detection of intercurrent infection in febrile patients with SLE. Ann Rheum Dis 60 (2001) 988-989
21. Paton N.I. Infections in systemic lupus erythematosus patients. Ann Acad Med Singapore 26 (1997) 694-700
22. Neilan B.A., and Berney S.N. Hyposplenism in systemic lupus erythematosus. J Rheumatol 10 (1983) 332-334
23. Falagas M.E., Manta K.G., Betsi G.I., and Pappas G. Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review. Clin Rheum 26 (2007) 663-670
24. Zandman-Goddard G., and Shoenfield Y. Infections and SLE. Autoimmunity 38 (2005) 473-485
25. Petri M., and Genovese M. Incidence and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins lupus cohort. J Rheumatol 19 (1992) 1559-1565
26. Ng W.L., Chu C.M., Wu A.K.L., Cheng V.C.C., and Yuen K.Y. Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus. Q J Med 99 (2006) 37-47
27. Gilliland W.R., and Tsokos G.C. Prophylactic use of antibiotics and immunisations in patients with SLE. Ann Rheum Dis 61 (2002) 191-192
28. Cervera R., Khamashta M.A., Font J., Sebastiani G.D., Gil A., Lavilla P., et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 82 (2003) 299-308